New intensive program aims to prevent suicide in At-Risk adults
NCT ID NCT07655986
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a high-resolution, multidisciplinary suicide prevention program for adults at moderate-to-high risk. Participants receive intensive follow-up from a team of nurses, psychiatrists, psychologists, and social workers over three months, plus weekly group therapy. The goal is to see if this program reduces suicide attempts and hospitalizations compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Suicide Prevention Program (PPS) - a behavioral intervention with intensive follow-up and group therapy
What this could lead to
If successful, this could provide an effective, community-based model for preventing suicide attempts and reducing hospitalizations.
What could go wrong
This is a relatively small, non-randomized study, so results may not apply broadly. The program is intensive and may not be feasible in all settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREVENTION OF SUICIDAL BEHAVIOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Salamanca, 37185, Spain